JP2016512555A5 - - Google Patents

Download PDF

Info

Publication number
JP2016512555A5
JP2016512555A5 JP2016501805A JP2016501805A JP2016512555A5 JP 2016512555 A5 JP2016512555 A5 JP 2016512555A5 JP 2016501805 A JP2016501805 A JP 2016501805A JP 2016501805 A JP2016501805 A JP 2016501805A JP 2016512555 A5 JP2016512555 A5 JP 2016512555A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
aki
stem cells
placental stem
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016501805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016512555A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/025266 external-priority patent/WO2014159826A1/en
Publication of JP2016512555A publication Critical patent/JP2016512555A/ja
Publication of JP2016512555A5 publication Critical patent/JP2016512555A5/ja
Pending legal-status Critical Current

Links

JP2016501805A 2013-03-14 2014-03-13 急性腎損傷の治療における胎盤幹細胞の使用 Pending JP2016512555A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361785252P 2013-03-14 2013-03-14
US61/785,252 2013-03-14
PCT/US2014/025266 WO2014159826A1 (en) 2013-03-14 2014-03-13 Use of placental stem cells in treatment of acute kidney injury

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018206365A Division JP2019055955A (ja) 2013-03-14 2018-11-01 急性腎損傷の治療における胎盤幹細胞の使用

Publications (2)

Publication Number Publication Date
JP2016512555A JP2016512555A (ja) 2016-04-28
JP2016512555A5 true JP2016512555A5 (https=) 2017-04-13

Family

ID=51625261

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016501805A Pending JP2016512555A (ja) 2013-03-14 2014-03-13 急性腎損傷の治療における胎盤幹細胞の使用
JP2018206365A Pending JP2019055955A (ja) 2013-03-14 2018-11-01 急性腎損傷の治療における胎盤幹細胞の使用
JP2020180987A Withdrawn JP2021038229A (ja) 2013-03-14 2020-10-29 急性腎損傷の治療における胎盤幹細胞の使用
JP2022176132A Pending JP2023022018A (ja) 2013-03-14 2022-11-02 急性腎損傷の治療における胎盤幹細胞の使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018206365A Pending JP2019055955A (ja) 2013-03-14 2018-11-01 急性腎損傷の治療における胎盤幹細胞の使用
JP2020180987A Withdrawn JP2021038229A (ja) 2013-03-14 2020-10-29 急性腎損傷の治療における胎盤幹細胞の使用
JP2022176132A Pending JP2023022018A (ja) 2013-03-14 2022-11-02 急性腎損傷の治療における胎盤幹細胞の使用

Country Status (8)

Country Link
US (2) US20160030488A1 (https=)
EP (1) EP2968420B1 (https=)
JP (4) JP2016512555A (https=)
DK (1) DK2968420T3 (https=)
ES (1) ES2703784T3 (https=)
PL (1) PL2968420T3 (https=)
PT (1) PT2968420T (https=)
WO (1) WO2014159826A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201991371A1 (ru) * 2016-12-05 2019-12-30 Селулэрити, Инк. Лечение лимфедемы и связанных состояний с использованием плацентарных адгезивных клеток
US10932711B2 (en) 2017-02-27 2021-03-02 Payman Sadeghi Method and system for neurohydrodissection
US10456419B2 (en) 2017-02-27 2019-10-29 Payman Sadeghi Method for treating migraine headaches

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
NZ534643A (en) * 2002-02-13 2010-06-25 Anthrogenesis Corp Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US7910755B2 (en) * 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
PL2471907T3 (pl) * 2005-12-29 2019-07-31 Celularity, Inc. Populacje komórek macierzystych łożyska
NZ612888A (en) * 2007-02-12 2015-02-27 Anthrogenesis Corp Treatment of inflammatory diseases using placental stem cells
ES2525718T3 (es) * 2007-10-05 2014-12-29 DePuy Synthes Products, LLC Reparación y regeneración de tejido renal mediante células derivadas de tejido de cordón umbilical humano
WO2009114826A2 (en) * 2008-03-13 2009-09-17 Angiodynamics, Inc. Treatment systems and methods for renal-related diseases
DK2556145T3 (en) * 2010-04-07 2016-11-07 Anthrogenesis Corp Angiogenesis using placental stem cells
EP2555783A1 (en) * 2010-04-08 2013-02-13 Anthrogenesis Corporation Treatment of sarcoidosis using placental stem cells
CA2841713A1 (en) * 2011-07-15 2013-01-24 Anthrogenesis Corporation Treatment of radiation injury using amnion derived adherent cells

Similar Documents

Publication Publication Date Title
JP2013523152A5 (https=)
HUE067965T2 (hu) Pimobendán alkalmazása a szív méretének csökkentésére és a klinikai tünetek megjelenésének késleltetésére mitrális billentyûbetegség okozta tünetmentes szívelégtelenségben szenvedõ betegeknél
JP2016512555A5 (https=)
JP2019526543A5 (https=)
JP2021529829A5 (https=)
JP2014507482A5 (https=)
HRP20240798T1 (hr) Terapija matičnim stanicama kod patologija endometrija
JP2015535291A5 (https=)
HK1245117A1 (zh) 使用调节释放索拉贝隆用於下尿路症状的组合物和方法
WO2017070689A3 (en) Solabegron zwitterion and uses thereof
IL285187A (en) Methods for treating symptoms and disorders associated with lysosomal storage diseases
HK1232145A1 (zh) 雙功能化合物和用於降低尿酸水平的用途
JP2014513121A5 (https=)
WO2014130313A3 (en) Methods and compositions relating to the treatment of cancer
JP2015516452A5 (https=)
JP2013520509A5 (https=)
Osadchuk et al. Effect of allopurinol on slowing allograft functional decline in kidney transplant recipients
MX2016009226A (es) Combinaciones farmaceuticas.
JP2015516451A5 (https=)
JP2013100268A5 (https=)
Gebhard et al. Metastatic neuroendocrine tumors to the liver: treatment with bland embolization versus radioembolization
JP2015516449A5 (https=)
WO2015057403A3 (en) Compositions and methods for treatment of inflammatory bowel disease
WO2016199161A3 (en) A composition comprising pentosan polysulfate sodium for use in treatment of bladder outlet obstruction and/or lower urinary tract symptoms
WO2009114088A3 (en) Fullerene therapies for inflammation